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S_ary This paper describes the results of a study set up to investigate factors associated with the high
proportions of 'death certificate only' registrations (DCOs) for all cancers registered in south-east England
between 1987 and 1989 and to identify those which might be subject to registry intervention. DCOs as a
proportion of all registrations (n = 162 131) were anlaysed by age, sex, district of residence, place of death and
survival. DCO registration ratios (standardised for age and sex) were then derived for each of the 56 districts
in the Thames Regions. A multiple logistic regression model was generated to estimate the effect of age at
diagnosis, tumour survival and patient sex on final source of registration. To minimise the number of dummy
vanables needed, each of the 56 distncts was ranked into quarfiles: quartile 1 contained the 14 districts with
the lowest age- and sex-standardised ratios for DCO registrations and quartile 4 comprised the 14 districts
with the highest DCO ratios. Final source of registration was treated as a binomial trial (case notes or death
certificates). The significance of associations was measured using the deviance difference as an approximate
chi-square statistic. The effect of each variable on source of registration was estimated as an odds ratio.
Interaction terms were also fitted. To estimate the effect of place of death on DCO registrations, a second
model was generated for deceased patients only (n = 98 455, adding 'place of death' to the list of explanatory
variables already used. A further interaction term was fitted to account for interaction between place of death
and district quartile of residence. Around 24% of all patient deaths were registered as DCOs by the Thames
Cancer Registry between 1987 and 1989. Of these, 40.9% died in an acute NHS hospital setting, 37.1% died at
home, 10.4% died in hospices and 3.4% died in non-NHS hospitals. Increasing age, decreasing survival,
district of residence and place of death were positively associated with death certificate registrations. The
district effect was sustained in the regression model with significant positive associations shown for DHA
quartile of residence. In the deceased group of patients, both district of residence and place of death were
independent predictors of DCOs. Death occurring outside the acute NHS hospital setting increased the odds
of being a DCO within and across district quartiles. DCOs could be reduced by better case ascertainment in
some districts. Quality assurance measures should include monitoring DCO rates by district, site and registry.
This would enable cancer registres to identify distncts and tumours at high risk of DCO registration and
enable the process of registrations and retrospective follow-up to be scrutinised. Changing patterns of
treatment and terminal care may make case ascertainmment and registration more difficult for registry staff in
the future, although the minmum contract data set should assist in this. The current trends to shorten lengths
of stay and increase day case and out-patient treatment could adversely affect registration and case ascertain-
ment, especially if fewer people die in hospital.
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Routine statistics on national cancer incidence and survival
are derived by the Office of Population Censuses and Surveys
(OPCS) from the 12 cancer registries of England and Wales
(OPCS and Cancer Research Campaign, 1981; OPCS, 1993).
They are used to monitor national trends in cancer incidence
and survival and as a baseline for epidemiological studies and
health services research (Swerdlow, 1986). In a recent study
we showed that the quality and reliability of registrations are
affected by the proportion of death certificate only registra-
tions (DCOs) held by the registry (Pollock and Vickers,
1994). DCOs are registrations based on death certificate in-
formation alone (Jensen et al., 1991).
Although OPCS holds no national data on DCOs, the
annual reports of the Thames Cancer Registry (TCR)
indicate that, between 1987 and 1989, DCOs constituted
23.8% of all registrations (Thames Cancer Registry, 1992).
Since 1983, a rapid increase has taken place in Thames DCO
rates. The registry has explained this rise by reference to the
decision taken in 1983 (for financial reasons) not to follow
up patients dying at home (Thames Cancer Registry, 1992).
A second reason for the high rate was the amalgamation of
the North Thames Regions, which only became part of the
territory covered by the TCR in 1985: the greatest concentra-
tion of DCOs was found in the North Thames Regions.
Thames DCO proportions compared unfavourably with
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those reported by registries elsewhere in England and Wales
of between 1.6% and 13.8% (England and Wales registries,
personal communications). Since 1992, the TCR has been
attempting to retrieve data on DCO cases (including those
patients dying at home) through family health services
authorities (FHSAs).
High DCO proportions may bias the calculation of
incidence, survival and treatment rates through inaccurate
coding of tumour site, date of diagnosis or cause of death
(Percy et al., 1981; Chow and Devesa, 1992; Pollock and
Vickers 1994a) or through loss of data (Silman and Evans,
1981; Swerdlow, 1986; Wilson et al., 1992; Pollock and
Vickers 1994b). Since it is usually impossible to confirm a
date of diagnosis for DCOs, they are excluded from survival
analysis.
The TCR covers a population of 13.8 million residents
within the four regional health authonties (RHAs) and 56
district health authorities (DHAs) in south-east England. It
contributes nearly a third ofall cases to the national data. Its
main sources of data for registration are clinical records and
death certificates supplied by OPCS. If, on the basis of death
certificate information, a place of treatment can be traced,
the registry attempts to obtain confirmation of the diagnosis
from the hospitals nearest to the place ofdeath, the certifying
physician or coroner. This process is called retrospective
follow-up. If a place of treatment is traced, the registry
attempts to supplement death certificate data with case note
data, using peripatetic research clerks. These clerks are
trained by the registry to abstract details from case notes in9 I Io bDCIsXSE E*i
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medical records departments. If no further information is
obtained on a death certificate registration, the rgiation is
termed a death certificate only registration (DCO) (Jensen et
al., 1991).
DCOs have been linked to 'the efficiency of initial cancer
registration procedures and the assiduousness with which
different registries and registry clerks seek confirmatory
evidence of the diagnosis of such cancers' (Wilson et al.,
1992). Although there are no previous studies of factors
assocated with DCOs, higher proportions ofDCOs might be
expcte among patients diagnosed post mortem, patients
dying at home, patients not receiving active treatment,
patients with short survival and patients treated at centres
which do not liaise with cancer registries (e.g. some private
institutions). This paper describes the results of a study set
up to investigate factors related to the high rates of DCOs
observed in the Thames Cancer Registry (TCR) between
1987 and 1989 and to ientify those which might be subject
to registry intervention. In particular, we wished to ascertain
whether place ofdeath, district ofresidence and survival time
affected DCO rates.
Methods
All patients resident in the four Thames regional health
authorities diagnosed as having cancer between 1987 and
1989 were identified from the Thames Cancer Registry
(n = 162 131). Death certificate only registrations (DCOs) as
a proportion of these ations were calculated by age,
sex, place of death and tumour site.
DCO registration ratios for all tumour sites combined were
caculated using indirect standation (as for standardised
mortality ratios) for each of the 56 district health authorities
in the four south Tbames regions (adjusted for age and sex).
Nimety-nine per cent confidnce intervals were alculated
using the method described by Gardner and Altman (1989).
The signii ofvariations was further measured using the
chi-square test for heterogenety described by Breslow and
Day (1987). Each district DCO ratio was ranked and
assigned to quartiles such that quartile 1 contained the 14
districts with the lowest DCO ratios and quartile 4 comprised
the 14 districts with the highest DCO ratios.
It might be expected that higher proportions of DCOs will
be found in districts with a higher incidence ofpoor survival
cancers, e.g. lung cancer. To adjust for district differences in
the ratio of high survival to low survival cancers 2 year
relative survival rates were calculated for the 15 most com-
mon primary tumour sites in each sex for all registrations
excluding DCOs (n = 104 370), using the Hakuinen com-
puter program (Hakulinen et al., 1988). Each case, including
DCOs (n = 134 927), was then assigned a survival coefficient
corresponding to the relative survival rate assocated with the
primary tumour site. Relative survival is the ratio of the
survival observed in a group of cancer patients to the sur-
vival expected if they were only subject to the general (all-
cause) mortality in a standard population. The standard
population used in this study was the England and Wales
population.
To test the significnce of the association between district
of residence and DCO registration while controlling for age
at diagnosis, tumour survival and patient sex, a (backwards
stepwise) multiple logistic regression model was generated.
The model used DHA quartiles rather than DHAs (to
minimise the number of dummy variables needed). Since our
measurement of survival is a proxy for tumour site (each site
has a different survival coefficient) we did not inchlde tumour
site as a separate variable. Final source of registration (case
notes or death certificates) was the outcome variable. Two
models were generated. The first included surviving patients
in order to obtain a wider range of survival times and ages at
diagnosis and thus esumate the effect of these vanables. The
second model examined patients only.
The significance of associations was measured using the
deviance difference (namely the change in deviance arsing
from the inclusion of each variable) as an approximate chi-
square statistic. All vanables were modeled as categorical
variables except age at diagnosis and survival coefficient
(which were modelled as continuous variables). The increased
risk associated with each variable for DCO registration is
measured in odds ratios. The modelling was carried out using
the 'proc logist' procedure in the SAS computer program
(SAS Institute, 1990).
To establish whether district of residence was a proxy
measure for place of death, a second model was generated
for decased patients only (n = 98 455), adding 'place of
death' to the list of explanatory variables already used.
In both models, interactions between all variables were
tested for and the final models include significant inter-
actions.
Resdt
Baseline analysis
Age and sex DCOs accounted for 23.8% ofall registrations.
Table I shows that death certificates as a proportion of all
registrations increased with age for both men and women.
Among men, the number of DCO registrations rose from
9.1% in the under40s to 32.4% in the 75 and over age
group. Among women, the increase was even greater: DCOs
accounted for 7.0% in the under-40s and 34.8% in the 75
and over age group. The odds of being registered as a DCO
at age 65-74, relative to a male patient aged under 40, were
2.91 for men and 2.73 for women. These rose to 4.77 and
5.31 respectively at age 75 and over.
Survival DCO proportions and 2 year relative survival rates
for non-DCO registrations for the 15 most common cancers
in men and women are shown in Tables II and Ill for three
survival categories: good, moderate and poor. DCO propor-
tions tend to increase with more aggressive tumours, with a
few exceptions. Good-survival tumours, such as testis and
skin cancer, have lower proportions of DCOs (less than
10%). In the moderate survival category, DCO proportions
ranged from 17% to 26%, except for multiple myeloma,
where DCOs made up 33% of all registrations. This figure is
similar to those for cancers associated with poor survival,
such as lung, stomach and pancreas. Breast cancer, which
has moderate to good survival, had 16% DCO registration.
The proportion ofDCOs increased signifintly with decreas-
ing survival in both men and women (Pearson correlation
coefficient, P<0.0001).
District effect Figure 1 shows the distribution of standard-
ised ratios for DCO registations (adjusted for age and sex)
for each DHA, with 99% confidence intervals. The chi-
square test for heterogeneity showed signint variations in
district ratios (X2 for heterogeneity = 1371.4, P<0.0001).
Place of death The distribution of deaths and DCO regis-
trations by place of death and quartie of residence is shown
in Table IV: 48.3% of deaths occurred in an acute NHS
hospital, 28% and 12% of all deaths arise at home and in
hospices r ely and there is variation across the four
quartl. Of the DCO registrations, 40.9% die in an acute
NHS hospitaL 37.1% at home and 10.4% in hospices; again
the proportions vary across the quartiles.
Multiple logistic regression models
Table V lists the significance ofassociations for each variable
with registration by DCO for all patients (alive and d
combined). The odds ratios presented for survival represents
the change in risk (ofregistration by DCO) associated with a
1% increase in 2 year relative survival rates. The odds ratios
presented for age at diagnosis represent the change in risk
associated with each added year at diagnosis. Table VI tests
for the signinc of associations between the same variablesFacdus r b DCOs iSE Ena
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on deceased patients only (adding place of death). In both
cohorts, all variables - DHA quartile, survival time, age, sex
and (in the deceased patients' cohort) place of death - were
strongly associated with DCO registration (P<O.001).
Significant interactions were found in both cohorts
between patient sex and survival and between patient sex and
age at diagnosis (P<0.01): females had better survival but
tended to be older than males. A further significant negative
interaction was found in the deceased patients' cohort
between DHA quartile of residence and place of death
(P<0.01). Quartile 1, comprising the districts with the
lowest DCO registration ratios, had the smallest proportion
of cases dying in the NHS and the largest proportion ofcases
dying at home, while the converse was true in quartile 4. The
fit of both models improved when age at diagonsis was
supplemented by the squared term (age at diagnosis squared),
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Table I Proportion ofregistrations by 'death certificate only' (DCOs) at theThames CancerRegistry. All cases, 1987-89, aged
under 100 years at diagnosis. By age group at diagnosis and sex (odds ratios are relative to male cases aged under 40 years)
Male cases Female cases
Age group vAears) DCOs (%) n Odds ratios (95% CIs) DCOs (%} n Odds ratios (95% CIs)
Under 40 9.14 3566 1.00 7.00 4345 0.75 (0.64-0.88)
40-64 17.59 20 554 2.12 (1.89-2.38) 13.25 25 639 1.52 (1.35-1.71)
65-74 22.63 25 603 2.91 (2.60-3.26) 21.54 21 093 2.73 (2.43-3.06)
75 and over 32.42 29 765 4.77 (4.29-5.31) 34.81 31 566 5.31 (4.78-5.81)
Total 24.39 79488 3.21 (2.88-3.58) 23.27 82643 3.01 (2.70-3.36)
P (trend) <0.0001 <0.0001
Table k Two year relative survival and percentage of DCO
registrations for the 15 most common sites for cancer in males
ICD code (tumour site) Survival DCOs (%) n'
Good survival
186 (testis) 93.10 2.36 1061
172 (skin) 76.34 9.50 1053
161 (larynx) 73.53 11.41 1209
188 (bladder) 69.07 12.02 6282
Moderate survival
185 (prostate) 56.44 22.59 9971
202 (lymphoid and histiocytic 48.66 22.94 2001
tissue)
154 (rectum) 48.30 16.62 3923
153 (colon) 42.55 24.46 5703
189 (kidney and other unspecified 42.39 21.50 1856
urinary organs)
203 (multiple myeloma) 33.10 32.52 1187
191 (brain) 24.33 17.21 1482
Poor survival
151 (stomach) 13.95 30.19 5062
150 (oesophagus) 11.70 24.82 2111
162 (lung) 10.73 28.79 20692
157 (pancreas) 6.82 33.68 2586
'Sumval is calculated for all cases except DCO cases.
Table M Two year relative survival and percentage of DCO
registrations for the 15 most common sites for cancer in females
Twnour site Survival DCOs (%) na
Good survival
172 (skin) 84.07 7.77 1712
174 (breast) 72.31 16.38 22403
180 (cervix uteri) 69.35 11.88 2686
182 (uterus) 69.35 12.51 3117
Moderate survival
188 (bladder) 58.13 16.81 2498
202 (lymphoid and histiocytic 47.41 21.34 1879
tissue)
154 (rectum) 47.17 19.18 3389
153 (colon) 41.08 26.36 7239
183 (ovary and other uterine 35.57 21.45 4331
adnexa)
189 (kidney and other unspecified 34.59 25.37 1088
urinary organs)
191 (brain) 26.79 22.83 1108
Poor survival
151 (stomach) 15.35 33.73 3217
150 (oesophagus) 12.26 26.82 1633
162 (lung) 9.89 30.22 9671
157 (pancreas) 5.05 36.01 2777
aSurvival is calculated for all cases except DCO cases.
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Fugwe 1 Standardised DCO registration ratios, Thames Cancer
Registry 1987-89, by DHA of residence. All tumour sites com-
bined with 99% confidence intervals.
Table IV Percentage distribution ofalldeathsand DCOs (in brackets)
in each quartile by place ofdeath. All percentages are based on quartile
totals
Place ofdeath
Acute NHS
Extra regional
Home
Hospice
Independent
Long-stay NHS
Nursing home
Oncology
Other hospital
Post-graduate
1
44.43
(30.21)
0.46
(0.73)
29.86
(44.93)
12.48
(10.18)
2.95
(3.85)
2.44
(4.24)
2.58
(4.04)
1.36
(0.71)
0.52
(0.65)
0.17
(0.20)
2
46.72
(37.57)
0.49
(0.73)
27.69
(39.19)
13.01
(10.03)
3.45
(5.72)
1.86
(2.68)
1.49
(2.05)
2.16
(1.07)
0.53
(0.64)
0.24
(0.22)
Quartile
3
49.08
(41.24)
0.53
(0.95)
30.03
(38.65)
9.50
(8.55)
1.11
(1.89)
1.53
(2.67)
1.93
(2.79)
0.91
(0.36)
2.87
(2.53)
0.51
(0.30)
4
52.73
(47.87)
0.33
(0.43)
25.08
(31.09)
12.75
(11.52)
1.72
(2.65)
2.64
(3.97)
0.88
(1.10)
0.54
(0.33)
0.48
(0.40)
1.03
(0.30)
All
48.32
(40.88)
0.45
(0.67)
28.29
(37.14)
12.00
(10.35)
2.32
(3.37)
2.13
(3.42)
1.69
(2.24)
1.24
(0.57)
1.05
(1.01)
0.56
(0.37)
Total deaths 24224 25099 22 740 26 392 98455
% deaths 100 100 100 100 100
Total DCOs
%DCOs
5373 6831 7301 11 052 30 557
100 100 100 100 100Facdsroi-d bDCs i SE -
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signifying that the relationship between age at diagnosis and
source of registration was non-linear.
Table VII shows that, within all quartles, the odds of
being registered as a DCO increase for patients dying in the
private sector, hospices and at home. Odds also broadly
increase by quartile (though odds are frequently higher in
DHA quartile 3 than in DHA quartile 4). For patients dying
in the private sector, the odds of being registered by DCO
(relative to patients registered in DHA quartile 1, dying in
the acute sector) were 2.74 in quartile 1, 3.24 in quartile 2,
4.03 in quartile 3 and 2.96 in quartile 4. For patients dying at
home the corresponding figures were 2.87, 5.62, 9.27 and 5.97
respectively.
Table V A logistic regression model for registration by DCO. Top 15 cancers for men and
women combined (n = 134 927). All patients, alive and deceased
Deviancedfference
Variable Odds ratio (95% CI) (XI) df. P
DHA quartik of 3100.60 3 <0.001
residence
Quartie
1 1
2 1.66 (1.27-2.17)
3 1.% (1.51-2.56)
4 2.13 (1.63-2.79)
Survival (%) 0.96 (0.96-0.97) 2031.84 1 <0.001
Age
At diagnosis (years) 1.00 (1.00-1.01) 6185.27 2 <0.001
Atdiagnissquared 1.00(1.00-1.01) <0.001
Sex (females vs males) 0.76 (0.63-0.92) 96.01 1 <0.001
TableVI A logistic regression model forregistration bydeathcertificate only (DCO). Top 15
cancers for men and women combined (n = 98 455). Daeased patients only
Deviance dfference
Variable Odds ratio (95% CIs) (XI) d.f. P
DHA quartile of 3417.36 3 <0.001
residence
Quartile
1 1
2 1.57 (1.47-1.68)
3 2.17 (2.03-2.32)
4 3.71 (3.48-3.95)
Survival (%) 0.99 (0.98-1.00) 95.53 1 <0.001
Age
At diais (ye) 1.04 (1.03-1.05) 2607.69 2 <0.001
At iagnosis squared 1.00(1.00-1.01)
Sex (femals vs males) 0.87 (0.82-0.92) 152.76 2 <0.001
Place ofdeath 3637.11 9 <0.001
Acute NHS hospital I
Extra regional 3.34 (2.12-5.26)
Home 2.87 (2.65-3.10)
Hospice 1.35 (120-1.51)
Independent hospital 2.74 (2.26-3.32)
Long-stay hospital 2.89 (2.36-3.53)
Nursing home 2.39 (1.92-2.98)
TCR area 2.73 (1.81-4.12)
unidentified hospital
Oncology 0.85 (0.57-1.26)
Post-graduate hospital 2.57 (1.25-5.30)
TableVII Multiplelogisticregressionmodel: deceasedpatientsonly. InteractionofplaceofdeathwithDHA
quartile ofrsdn. Odds ofbeing registered by DCO (relative tocases resident in DHA quartile 1 dying in
the acute sector)
Odds ratios
Quartile 1 Quartik 2 Quartile 3 Quartile 4
(lowest DCO (second lowest (secondhighest (highest DCO
Place ofdeath ratios) DCO ratios) DCO ratios) ratios)
Acute NHS hospital 1.00 1.57 2.17 3.71
Extra regional 3.34 6.83 6.20 5.67
Home 2.87 5.62 9.27 5.97
Hospice 1.35 2.81 3.39 4.72
Independent hospital 2.74 3.24 4.03 2.96
Long-stay hospital 2.89 6.91 6.74 4.81
Nursing home 2.39 5.34 7.05 6.62
TCR area, unidentified hospital 2.73 5.84 10.67 11.68
Oncology 0.85 1.79 3.82 5.43
Post-graduate hospital 2.57 7.38 20.25 39.05
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DCOs accounted for a quarter ofall regstrations in the TCR
between 1987 and 1989. This compares unfavourably with
rates given by other mgistries in England and Waks, which
ranged from 1.6% to 13.8%. The factors we found to be
associated with DCO registration were: increasing age,
decreasing survival, district of residence and place of death.
Between 1987 and 1989, the over-65s accounted for 67.2% of
all registered cases but 80.8% of DCO registrations. Age at
diagnsis also interacts with survival time, so that the in-
rease in DCO registrations with age is partly a function of
shorter survival time. And survival time is, in turn, strongly
correlated with tumour site.
The aim of this study was to ascertain factors associated
with DCOs that might be amenable to registry intervention.
We identified three factors which merit further investigation:
tumour site, distict of redence and place of death.
For all tumour sites, DCO rates are very high: for exam-
ple, it is unlikely either that 16.6% of breast cancers or that
9.5% of sklin cancers would be diagnosed only at death.
Some tumour sites such as multiple myeloma appear to have
disproportionately large numbers of DCO registrations,
which suggets that some aspect of the treatment process or
stting makes registration more difficult.
After adjustng for age and sex, there are ignificant varia-
tions in DCO ratios by district of rinc. However, these
do not take account of differences in tumour site and sur-
vival. Districts with high rates ofpoor-survival cancers might
be expected to have higher DCO rates, as they would have
kss time to regiser cases in life. Inded, the observed varia-
tions in district DCO ratios could be a function of inter-
district differences in the burden of disease (Table IV).
However, our multiple logistic regression models indicate
that district differences in DCO rates persist, even after
adjusting for differences in age, sex and survival time.
Patients residnt in the fourth quartie dying in the acute
stor were 3.71 times more likely to be rgistered as DCO
cases than their counterparts in the first quartile. In the
cohort comprisng deceased patients only, we were able to
confirm that the strong association with DHA quartile of
dence was independent of place of death. This is consis-
tent with an observation reported in a previous study that
the organisation of medical records departments appeared to
affect the ability of clerks and researchers to retrieve notes
(Vickers and Pollock, 1993).
However, nearly 41% of all DCO patients die in the acute
NHS hospital sector, which suggsts both a failure of ascer-
tainment and a failure of DCO registration procedures in
acute NHS hospital settings. More efficient registrations at
NHS hospitals could dramatically reduce the proportion of
DCOs in Thames.
Dying outside the NHS also increases the odds of being a
DCO, so that in quartik 1 elevated odds ratios (relative to
patients dying in the acute sector) were also found for
patients dying in hospices (OR= 1.35), long-stay treatment
centres (OR = 2.89), nursing homes (OR = 2.39) and private
institutions (OR = 2.74). These results suggest that changing
patterns of care will have serious implications for the ability
of regisries to ascertain cases both prospectively and retro-
spectively. Shorter lengths of stay and more day case and
out-patient treatments may make it harder for registry clerks
to retriev notes and ascertain cases. It is to be hoped that
the introduction ofthe minimum contract data set for cancer
will counteract these developments (NHS ME Executive Let-
ter, EL(92)95). Greater use of the private sector and hospices
may also make registration more difficult and time-
consuming for cerks attempting to retneve retrospective in-
formation on cases ascertained by death certificte as neither
the private sector nor hospic are bound by the minimum
contract data set to provide information to the cancer regis-
tries.
Conchuion
OPCS and cancer registries should collect routine data on
DCOs by site, district of residence and place of death.
Cancer registration quality assuranc programmes should use
these measures to improve the efficency of case ascertain-
ment and ristration programmes and to consider the
implications of high rates of DCOs for cancer registration.
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